Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Scott Technology (SCT) / HY22

Cash flow flipped to -NZ$8.8m on a NZ$14.9m working-capital build

Revenue rose 13.3% and PBT 21.3%, but inventory absorption and a doubled dividend pushed net debt/EBITDA to 1.06x from 0.26x.

Industrials / Automation and robotics

SCT revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $128.2m, versus $275.3m in FY25.

SCT EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • FY21 SCT: Unprecedented low ebitda margin. 10.2%; 4-period range 10.8% to 11.5%. EBITDA margin: 10.2%, unprecedented low; 4-period mean 11.1%, range 10.8%-11.5%.
  • HY24 SCT: Unprecedented high ebitda margin. 11.8%; 4-period range 10% to 11.5%. EBITDA margin: 11.8%, unprecedented high; 4-period mean 10.5%, range 10.0%-11.5%.
  • HY25 SCT: Outside range low ebitda margin. 10%; 4-period range 10.2% to 11.8%. EBITDA margin: 10.0%, below normal range; 4-period mean 10.9%, range 10.2%-11.8%.
  • FY25 SCT: Outside range high ebitda margin. 11.5%; 4-period range 10.2% to 11.3%. EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.
EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.

SCT operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $6.1m, versus $22.3m in FY25.

SCT working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • FY21 SCT: Outside range low operating working-capital movement. $6.3m; 4-period range $7.2m to $18.1m. Operating working-capital movement: NZ$6.3m, below normal range; 4/4 prior periods had builds averaging NZ$10.9m, and none had a working-capital release.
  • HY23 SCT: Unprecedented low operating working-capital movement. $-4.9m; 4-period range $4.6m to $25.9m. Operating working-capital movement: NZ$-4.9m, unprecedented low; 4/4 prior periods had builds averaging NZ$14.6m, and none had a working-capital release.
  • HY24 SCT: Unprecedented high operating working-capital movement. $25.9m; 4-period range $-4.9m to $14.9m. Operating working-capital movement: NZ$25.9m, unprecedented high; 3/4 prior periods had builds averaging NZ$10.8m, and 1 had releases averaging NZ$-4.9m.
  • FY25 SCT: Unprecedented high operating working-capital movement. $18.1m; 4-period range $6.3m to $10.7m. Operating working-capital movement: NZ$18.1m, unprecedented high; 4/4 prior periods had builds averaging NZ$8.0m, and none had a working-capital release.
Operating working-capital movement: NZ$18.1m, unprecedented high; 4/4 prior periods had builds averaging NZ$8.0m, and none had a working-capital release.
Release date
7 April 2022
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY22 vs HY21

Revenue

$118.4m

+13.3% ↑ vs $104.5m

EBITDA

$12.2m

+8.8% ↑ vs $11.2m

Net profit after tax

$4.7m

flat vs $4.7m

Net cash inflow from operating activities

−$8.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Interim dividend per share

4.0c

+100.0% ↑ vs 2.0c

Profit before tax

$7.4m

+21.3% ↑ vs $6.1m

Cash and cash equivalents

$13.7m

+121.7% ↑ vs $6.2m

Total assets

$210.8m

+19.3% ↑ vs $176.6m

What changed

Operating cash flow swung from +NZ$5.3m to -NZ$8.8m, driven by a NZ$14.9m working-capital build that sits above Annolyse's historical baseline (4-period mean NZ$6.4m; prior builds averaged NZ$10.1m)

Inventories rose 51.6% to NZ$28.5m, with contract assets at NZ$29.5m absorbing further cash.

Reported earnings looked stronger than NPAT suggests: revenue +13.3% to NZ$118.4m (above the supplied historical range, mean 2.5%), EBITDA +8.8% to NZ$12.2m and PBT +21.3% to NZ$7.4m. NPAT was flat at 0.0% because the effective tax rate moved to 36.2% — an unprecedented high versus the historical mean of 20.5% — from -22.2% in HY21, which carried a tax credit.

Gross borrowings nearly tripled to NZ$26.7m and net debt/EBITDA rose to 1.06x from 0.26x. The interim dividend doubled to 4.0cps.

What matters

Cash conversion broke down

OCF/EBITDA at -72.7% (vs +47.2% prior) is below the supplied historical range. The build is not a receivables problem — debtor days actually improved to 48.8 from 55.3 — it is inventory and contract-asset positioning. For a project-based industrial this can be milestone timing, but it forces the leverage step-up and puts the read on H2 delivery execution rather than the H1 P&L.

Tax distortion masks the operating read. PBT +21.3% is the cleaner measure; the 21.3pp gap to NPAT growth is entirely tax. With the ETR an unprecedented 36.2% against a 20.5% historical mean, headline NPAT growth of 0.0% understates underlying operating improvement.

Payout ratio versus pre-lease FCF is suppressed because the source-backed cash-dividend bridge is unavailable.

Expectations

No forward target was supplied and no implied-shape context is available; in dollar terms the HY22 result already runs ahead of HY21 by NZ$13.9m on revenue and the H1 run-rate annualises at NZ$236.8m

Management commentary cites robust forward work across Europe, the USA and China, but the supplied excerpts do not quantify order book or margin.

The central unanswered question is whether the inventory and contract-asset build converts to deliveries and cash in H2 or carries forward. The release supports the operating-growth narrative but does not resolve the cash conversion path.

Quality of result

Top-line and operating-profit quality look durable — revenue growth is above-normal, PBT is up 21.3%, and capex held at 1.0% of revenue — but the cash bridge is weak

FCF/NPAT at -212.2% means every dollar of headline profit consumed more than two dollars of cash this half. Pre-lease FCF at -NZ$10.0m sits at the lower edge of the historical range despite restrained capex, so the gap is entirely working capital.

Segment quality is mixed and concentrates the result. Australasia Manufacturing drove the group: revenue up to NZ$62.1m at a 19.7% disclosed gross margin and a segment result of NZ$12.2m versus NZ$7.3m prior. Americas Manufacturing reversed to a -NZ$0.2m result on a -1.1% gross margin (from NZ$3.2m prior), and China's result fell to NZ$0.3m from NZ$1.5m. Group earnings durability therefore depends on Australasia continuing to offset regional weakness, which the release does not explain.

Unresolved

Open questions

What proportion of the NZ$14.9m working-capital build is committed inventory against signed contracts versus speculative positioning?
When does the NZ$29.5m contract asset balance convert to billed receivables and cash, and what milestones drive it?
Why did the effective tax rate move to 36.2%, and is it a one-off jurisdictional mix issue or a permanent step-up?
Why did Americas Manufacturing reverse to a segment loss, and what is the path back to breakeven?
Is the doubled interim dividend sustainable if H2 does not reverse the H1 working-capital absorption, given gross borrowings already tripled to NZ$26.7m?

This briefing cannot assess forward order-book composition, contract milestone timing, or the durability of the current tax outcome.

Chat

Ask about SCT HY22

Ask follow-up questions about Scott Technology's HY22 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SCT HY22

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Scott Technology's HY22 result.

What proportion of the NZ$14.9m working-capital build is committed inventory against signed contracts versus speculative positioning?Why does "Cash conversion broke down" matter?How strong was the cash and earnings quality in HY22?What should I watch next for SCT after HY22?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

2022 Half Year Financial Statements

HY22 / financial report↗

2022 Half Year Investor Presentation

HY22 / results presentation↗

2022 Half Year Results Announcement

HY22 / results release↗

company filing

HY22 / results announcement↗

Prior comparable period

2021 Half Year Financial Statements

HY21 / financial report↗

2021 Half Year Results Announcement

HY21 / results release↗

company filing

HY21 / results announcement↗

Full-year context

NZX Results Announcement

FY21 / results announcement↗

NZX Results Announcement

FY21 / results release↗

Scott Annual Report 2021

FY21 / financial report↗

Release context

Annual Meeting Results 2021

HY22 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 21.3pp, with a distortion flag in the result.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 1.06x, +0.80x versus the prior comparable period.

→

Working-capital pressure

Inventory days were 44 days, +11 days versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 66.7%.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SCT publishes next

Get the next Scott Technology briefing and related NZX reporting-season updates by email.